442 related articles for article (PubMed ID: 31265124)
21. Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda.
Ziegler J; Newton R; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Reeves G; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C;
Int J Cancer; 2003 Jan; 103(2):233-40. PubMed ID: 12455038
[TBL] [Abstract][Full Text] [Related]
22. Kaposi's sarcoma-associated herpesvirus seroprevalence in selected german patients: evaluation by different test systems.
Preiser W; Szép NI; Lang D; Doerr HW; Rabenau HF
Med Microbiol Immunol; 2001 Dec; 190(3):121-7. PubMed ID: 11827200
[TBL] [Abstract][Full Text] [Related]
23. Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide.
Davis DA; Humphrey RW; Newcomb FM; O'Brien TR; Goedert JJ; Straus SE; Yarchoan R
J Infect Dis; 1997 May; 175(5):1071-9. PubMed ID: 9129068
[TBL] [Abstract][Full Text] [Related]
24. Risk Factors for Kaposi's Sarcoma-Associated Herpesvirus DNA in Blood and in Saliva in Rural Uganda.
Nalwoga A; Nakibuule M; Marshall V; Miley W; Labo N; Cose S; Whitby D; Newton R
Clin Infect Dis; 2020 Aug; 71(4):1055-1062. PubMed ID: 31555829
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus.
Bigi R; Landis JT; An H; Caro-Vegas C; Raab-Traub N; Dittmer DP
Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11379-E11387. PubMed ID: 30429324
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus infection and expression in oral lesions.
Raab-Traub N; Webster-Cyriaque J
Oral Dis; 1997 May; 3 Suppl 1():S164-70. PubMed ID: 9456682
[TBL] [Abstract][Full Text] [Related]
27. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
28. Infection with Kaposi's sarcoma-associated herpesvirus among families of patients with classic Kaposi's sarcoma.
Guttman-Yassky E; Kra-Oz Z; Dubnov J; Friedman-Birnbaum R; Segal I; Zaltzman N; Roth T; Schwartz F; Linn S; Rozenman D; David M; Silbermann M; Barchana M; Bergman R; Sarid R
Arch Dermatol; 2005 Nov; 141(11):1429-34. PubMed ID: 16301390
[TBL] [Abstract][Full Text] [Related]
29. Oral EBV and KSHV infection in HIV.
Webster-Cyriaque J; Duus K; Cooper C; Duncan M
Adv Dent Res; 2006 Apr; 19(1):91-5. PubMed ID: 16672557
[TBL] [Abstract][Full Text] [Related]
30. Mutual inhibition between Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus lytic replication initiators in dually-infected primary effusion lymphoma.
Jiang Y; Xu D; Zhao Y; Zhang L
PLoS One; 2008 Feb; 3(2):e1569. PubMed ID: 18253508
[TBL] [Abstract][Full Text] [Related]
31. Determinants of Gammaherpesvirus Shedding in Saliva Among Ugandan Children and Their Mothers.
Newton R; Labo N; Wakeham K; Marshall V; Roshan R; Nalwoga A; Sebina I; Muhangi L; Webb EL; Miley W; Rochford R; Elliott AM; Whitby D
J Infect Dis; 2018 Aug; 218(6):892-900. PubMed ID: 29762709
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy.
Labo N; Miley W; Benson CA; Campbell TB; Whitby D
AIDS; 2015 Jun; 29(10):1217-25. PubMed ID: 26035321
[TBL] [Abstract][Full Text] [Related]
33. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.
Min J; Katzenstein DA
AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052
[TBL] [Abstract][Full Text] [Related]
34. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma.
Whitby D; Howard MR; Tenant-Flowers M; Brink NS; Copas A; Boshoff C; Hatzioannou T; Suggett FE; Aldam DM; Denton AS
Lancet; 1995 Sep; 346(8978):799-802. PubMed ID: 7674745
[TBL] [Abstract][Full Text] [Related]
35. The Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) in Kaposi's sarcoma, malignant lymphoma, and other diseases.
Knowles DM; Cesarman E
Ann Oncol; 1997; 8 Suppl 2():123-9. PubMed ID: 9209655
[TBL] [Abstract][Full Text] [Related]
36. Reduced seroprevalence of Kaposi's sarcoma-associated herpesvirus (KSHV), human herpesvirus 8 (HHV8), related to suppression of Anopheles density in Italy.
Coluzzi M; Calabrò ML; Manno D; Chieco-Bianchi L; Schulz TF; Ascoli V
Med Vet Entomol; 2003 Dec; 17(4):461-4. PubMed ID: 14651663
[TBL] [Abstract][Full Text] [Related]
37. Kaposi's sarcoma and HTLV-III: a study in Nigerian adult males.
Otu AA
J R Soc Med; 1986 Sep; 79(9):510-4. PubMed ID: 3021963
[TBL] [Abstract][Full Text] [Related]
38. Kaposi's sarcoma-associated herpesvirus transmission and primary infection.
Bagni R; Whitby D
Curr Opin HIV AIDS; 2009 Jan; 4(1):22-6. PubMed ID: 19339936
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal analysis of the humoral response to Kaposi's sarcoma-associated herpesvirus after primary infection in children.
Olp LN; Minhas V; Gondwe C; Poppe LK; Rogers AM; Kankasa C; West JT; Wood C
J Med Virol; 2016 Nov; 88(11):1973-81. PubMed ID: 27062052
[TBL] [Abstract][Full Text] [Related]
40. Kaposi's sarcoma-associated herpesvirus-like DNA sequences (KSHV/HHV-8) in oral AIDS-Kaposi's sarcoma: a PCR and clinicopathologic study.
Flaitz CM; Jin YT; Hicks MJ; Nichols CM; Wang YW; Su IJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Feb; 83(2):259-64. PubMed ID: 9117759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
